Keenan, M.M.KeenanHoward, C.C.HowardTate, T.T.TateMcGuiness, I.I.McGuinessSauer-Budge, A.A.Sauer-BudgeBlack, J.J.BlackUtzinger, U.U.UtzingerBarton, J.K.J.K.Barton2022-03-132022-03-132016https://publica.fraunhofer.de/handle/publica/39604110.1117/12.2213345The 5-year survival rate for ovarian cancer is only 45% largely due to lack of effective screening methods. Current methods include palpation, transvaginal ultrasound, and the CA-125 blood test. Finding disease reliably and at an early stage increase survival to 92%. We have designed and built a 0.7 mm endoscope for the early detection of ovarian cancer. Inserted transvaginally through the working channel of a hysteroscope, the falloposcope creates a minimally invasive procedure for the screening of high risk women. To improve the ease-of-use and safety of falloposcope deployment, we are working to create an everting balloon. Currently, the falloposcope would require a skilled user to operate due to the challenging anatomy of the fallopian tubes - a small opening from the uterus (< 1 mm), tortuous path, and delicate lumenal features. A balloon delivery system would gently open the fallopian tube and guide the falloposcope down the center of lumen.enconference paper